{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:39:22Z","timestamp":1794267562317,"version":"4.9.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T00:00:00Z","timestamp":1579737600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T00:00:00Z","timestamp":1579737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ozenoxacin is a topical quinolone showing potent antimicrobial activities against Gram-negative and Gram-positive bacteria and is widely used for the treatment of inflammatory acne. However, the anti-inflammatory activities of ozenoxacin have not been examined so far. In the present study, we investigated the in vitro and in vivo anti-inflammatory effects of ozenoxacin. The production of interleukin (IL)-6 and IL-8 by human epidermal keratinocytes stimulated by heat-killed <jats:italic>Cutibacterium acnes<\/jats:italic> was significantly inhibited by ozenoxacin at concentrations from 1 to 30\u2009\u03bcg\u2009ml<jats:sup>\u22121<\/jats:sup>. Likewise, the production of IL-6, IL-8, and tumor necrosis factor alpha by stimulated THP-1 cells, a human monocyte cell line, was inhibited by ozenoxacin at concentrations from 1 to 30\u2009\u03bcg\u2009ml<jats:sup>\u22121<\/jats:sup>. The production of IL-1\u03b2 by THP-1 was also inhibited by ozenoxacin at the concentration of 30\u2009\u03bcg\u2009ml<jats:sup>\u22121<\/jats:sup>. Phosphorylation of the mitogen<jats:bold>-<\/jats:bold>activated protein kinases and degradation of I\u03baB-\u03b1, an inhibitory factor of NF-\u03baB in keratinocytes and THP-1 cells, was increased by stimulation with heat-killed <jats:italic>C. acnes<\/jats:italic>. Of these activated intracellular pathways, the p38 phosphorylation pathway was remarkably reduced by ozenoxacin in both keratinocytes and THP-1 cells. In addition, the application of 2% ozenoxacin suppressed the increase in the ear thickness of rats induced by an intracutaneous injection of heat-killed <jats:italic>C. acnes<\/jats:italic>. These findings suggest that ozenoxacin possesses an anti-inflammatory activity, which may contribute to its therapeutic effects on inflammatory acne.<\/jats:p>","DOI":"10.1038\/s41429-020-0278-5","type":"journal-article","created":{"date-parts":[[2020,1,23]],"date-time":"2020-01-23T08:03:14Z","timestamp":1579766594000},"page":"247-254","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Anti-inflammatory effects of ozenoxacin, a topical quinolone antimicrobial agent"],"prefix":"10.1038","volume":"73","author":[{"given":"Keisuke","family":"Tabara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachi","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamichi","family":"Kitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koki","family":"Fujikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Fujikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoji","family":"Kanayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideya","family":"Uratsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiaki","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsumi","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,23]]},"reference":[{"key":"278_CR1","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S0140-6736(11)60321-8","volume":"379","author":"HC Williams","year":"2012","unstructured":"Williams HC, Dellavalle RP, Garner S. Acne vulgaris. Lancet. 2012;379:361\u201372.","journal-title":"Lancet."},{"key":"278_CR2","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1111\/j.1600-0625.2009.00890.x","volume":"18","author":"I Kurokawa","year":"2009","unstructured":"Kurokawa I, et al. New developments in our understanding of acne pathogenesis and treatment. Exp Dermatol. 2009;18:821\u201332.","journal-title":"Exp Dermatol"},{"key":"278_CR3","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000068476","volume":"206","author":"A Koreck","year":"2003","unstructured":"Koreck A, Pivarcsi A, Dobozy A, Kem\u00e9ny L. The role of innate immunity in the pathogenesis of acne. Dermatology. 2003;206:96\u2013105.","journal-title":"Dermatology."},{"key":"278_CR4","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/sj.cdd.4401850","volume":"13","author":"T Kawai","year":"2006","unstructured":"Kawai T, Akira S. TLR signaling. Cell Death Differ. 2006;13:816\u201325.","journal-title":"Cell Death Differ"},{"key":"278_CR5","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.4049\/jimmunol.169.3.1535","volume":"169","author":"J Kim","year":"2002","unstructured":"Kim J, et al. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol. 2002;169:1535\u201341.","journal-title":"J Immunol."},{"key":"278_CR6","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1111\/j.0022-202X.2005.23705.x","volume":"124","author":"I Nagy","year":"2005","unstructured":"Nagy I, et al. Distinct strains of Propionibacterium acnes induce selective human beta-defensin-2 and interleukin-8 expression in human keratinocytes through toll-like receptors. J Investig Dermatol. 2005;124:931\u20138.","journal-title":"J Investig Dermatol"},{"key":"278_CR7","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1016\/j.micinf.2006.04.001","volume":"8","author":"I Nagy","year":"2006","unstructured":"Nagy I, et al. Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines\/chemokines in human sebocytes. Microbes Infect. 2006;8:2195\u2013205.","journal-title":"Microbes Infect."},{"key":"278_CR8","doi-asserted-by":"publisher","first-page":"3158","DOI":"10.1128\/IAI.63.8.3158-3165.1995","volume":"63","author":"BR Vowels","year":"1995","unstructured":"Vowels BR, Yang S, Leyden JJ. Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne. Infect Immun. 1995;63:3158\u201365.","journal-title":"Infect Immun"},{"key":"278_CR9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1159\/000087011","volume":"211","author":"J Kim","year":"2005","unstructured":"Kim J. Review of the innate immune response in acne vulgaris: activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses. Dermatology. 2005;211:193\u20138.","journal-title":"Dermatology."},{"key":"278_CR10","doi-asserted-by":"publisher","first-page":"392","DOI":"10.4103\/ijd.IJD_435_17","volume":"62","author":"K Sardana","year":"2017","unstructured":"Sardana K, Verma G. Propionibacterium acnes and the Th1\/Th17 axis, implications in acne pathogenesis and treatment. Indian J Dermatol. 2017;62:392\u20134.","journal-title":"Indian J Dermatol"},{"key":"278_CR11","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1016\/S0002-9440(10)62479-0","volume":"166","author":"S Kang","year":"2005","unstructured":"Kang S, et al. Inflammation and extracellular matrix degradation mediated by activated transcription factors nuclear factor-kappaB and activator protein-1 in inflammatory acne lesions in vivo. Am J Pathol. 2005;166:1691\u20139.","journal-title":"Am J Pathol"},{"key":"278_CR12","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/jid.2013.438","volume":"134","author":"M Kistowska","year":"2014","unstructured":"Kistowska M, et al. IL-1\u03b2 drives inflammatory responses to propionibacterium acnes in vitro and in vivo. J Investig Dermatol. 2014;134:677\u201385.","journal-title":"J Investig Dermatol"},{"key":"278_CR13","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/sj.jid.5700213","volume":"126","author":"NR Trivedi","year":"2006","unstructured":"Trivedi NR, Gilliland KL, Zhao W, Liu W, Thiboutot DM. Gene array expression profiling in acne lesions reveals marked upregulation of genes involved in inflammation and matrix remodeling. J Investig Dermatol. 2006;126:1071\u20139.","journal-title":"J Investig Dermatol"},{"key":"278_CR14","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1111\/1346-8138.14355","volume":"45","author":"N Hayashi","year":"2018","unstructured":"Hayashi N, et al. Japanese Dermatological Association Guidelines: guidelines for the treatment of acne vulgaris 2017. J Dermatol. 2018;45:898\u2013935.","journal-title":"J Dermatol."},{"issue":"Suppl 1","key":"278_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1468-3083.2011.04374.x","volume":"26","author":"A Nast","year":"2012","unstructured":"Nast A, et al. European evidence-based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol. 2012;26(Suppl 1):1\u201329.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"278_CR16","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jaad.2015.12.037","volume":"74","author":"AL Zaenglein","year":"2016","unstructured":"Zaenglein AL, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74:945\u201373.","journal-title":"J Am Acad Dermatol"},{"key":"278_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jdermsci.2005.01.002","volume":"38","author":"K Kuwahara","year":"2005","unstructured":"Kuwahara K, Kitazawa T, Kitagaki H, Tsukamoto T, Kikuchi M. Nadifloxacin, an antiacne quinolone antimicrobial, inhibits the production of proinflammatory cytokines by human peripheral blood mononuclear cells and normal human keratinocytes. J Dermatol Sci. 2005;38:47\u201355.","journal-title":"J Dermatol Sci"},{"key":"278_CR18","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.jiac.2016.03.006","volume":"22","author":"S Kanayama","year":"2016","unstructured":"Kanayama S, et al. In vitro antimicrobial activity of ozenoxacin against methicillin-susceptible Staphylococcus aureus, methicillin-resistant S. aureus and Streptococcus pyogenes isolated from clinical cutaneous specimens in Japan. J Infect Chemother. 2016;22:720\u20133.","journal-title":"J Infect Chemother"},{"key":"278_CR19","doi-asserted-by":"publisher","first-page":"6389","DOI":"10.1128\/AAC.01509-13","volume":"57","author":"Y L\u00f3pez","year":"2013","unstructured":"L\u00f3pez Y, et al. In vitro activity of Ozenoxacin against quinolone-susceptible and quinolone-resistant gram-positive bacteria. Antimicrob Agents Chemother. 2013;57:6389\u201392.","journal-title":"Antimicrob Agents Chemother"},{"key":"278_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/jac\/dku375","volume":"70","author":"Y L\u00f3pez","year":"2015","unstructured":"L\u00f3pez Y, et al. In vitro selection of mutants resistant to ozenoxacin compared with levofloxacin and ciprofloxacin in Gram-positive cocci. J Antimicrob Chemother. 2015;70:57\u201361.","journal-title":"J Antimicrob Chemother"},{"key":"278_CR21","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1099\/jmm.0.000293","volume":"65","author":"A Nakajima","year":"2016","unstructured":"Nakajima A, et al. Antimicrobial activities of ozenoxacin against isolates of propionibacteria and staphylococci from Japanese patients with acne vulgaris. J Med Microbiol. 2016;65:745\u201350.","journal-title":"J Med Microbiol"},{"key":"278_CR22","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.diagmicrobio.2013.11.010","volume":"78","author":"M Tato","year":"2014","unstructured":"Tato M, et al. Characterization of variables that may influence ozenoxacin in susceptibility testing, including MIC and MBC values. Diagn Microbiol Infect Dis. 2014;78:263\u20137.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"278_CR23","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/jac\/49.3.455","volume":"49","author":"T Yamakawa","year":"2002","unstructured":"Yamakawa T, Mitsuyama J, Hayashi K. In vitro and in vivo antibacterial activity of T-3912, a novel non-fluorinated topical quinolone. J Antimicrob Chemother. 2002;49:455\u201365.","journal-title":"J Antimicrob Chemother"},{"key":"278_CR24","first-page":"155","volume":"31","author":"M Kawashima","year":"2015","unstructured":"Kawashima M, et al. A comparative phase III study of ozenoxacin lotion in patients with acne vulgaris. J Clin Ther Med. 2015;31:155\u201371.","journal-title":"J Clin Ther Med"},{"key":"278_CR25","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/1523-1747.ep12264715","volume":"83","author":"LM De Young","year":"1984","unstructured":"De Young LM, Young JM, Ballaron SJ, Spires DA, Puhvel SM. Intradermal injection of Propionibacterium acnes: a model of inflammation relevant to acne. J Investig Dermatol. 1984;83:394\u20138.","journal-title":"J Investig Dermatol"},{"key":"278_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/439258","volume":"2015","author":"Kyoji Sekiguchi","year":"2015","unstructured":"Sekiguchi K. et al. Suppression of Propionibacterium acnes-induced dermatitis by a traditional Japanese medicine, jumihaidokuto, modifying macrophage functions. Evid Based Complement Alternat Med. 2015;2015:439258.","journal-title":"Evidence-Based Complementary and Alternative Medicine"},{"key":"278_CR27","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1346-8138.1991.tb03077.x","volume":"18","author":"H Akamatsu","year":"1991","unstructured":"Akamatsu H, Nishijima S, Takahashi M, Ushijima T, Asada Y. Effects of subminimal inhibitory concentrations of erythromycin, tetracycline, clindamycin, and minocycline on the neutrophil chemotactic factor production in Propionibacterium acnes biotypes 1-5. J Dermatol. 1991;18:247\u201351.","journal-title":"J Dermatol."},{"key":"278_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1177\/030006059502300103","volume":"23","author":"H Akamatsu","year":"1995","unstructured":"Akamatsu H, et al. Effect of nadifloxacin on neutrophil functions. J Int Med Res. 1995;23:19\u201326.","journal-title":"J Int Med Res"},{"key":"278_CR29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/1523-1747.ep12543487","volume":"70","author":"NB Esterly","year":"1978","unstructured":"Esterly NB, Furey NL, Flanagan LE. The effect of antimicrobial agents on leukocyte chemotaxis. J Investig Dermatol. 1978;70:51\u20135.","journal-title":"J Investig Dermatol"},{"key":"278_CR30","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jdermsci.2009.08.001","volume":"56","author":"PA Grange","year":"2009","unstructured":"Grange PA, Raingeaud J, Calvez V, Dupin N. Nicotinamide inhibits Propionibacterium acnes-induced IL-8 production in keratinocytes through the NF-\u03baB and MAPK pathways. J Dermatol Sci. 2009;56:106\u201312.","journal-title":"J Dermatol Sci"},{"key":"278_CR31","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1039\/C5FO00550G","volume":"6","author":"WC Huang","year":"2015","unstructured":"Huang WC, et al. Inhibitory effects of wild bitter melon leaf extract on Propionibacterium acnes-induced skin inflammation in mice and cytokine production in vitro. Food Funct. 2015;6:2550\u201360.","journal-title":"Food Funct."},{"key":"278_CR32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s13555-015-0072-7","volume":"5","author":"WH Li","year":"2015","unstructured":"Li WH, et al. p38 MAP kinase inhibition reduces Propionibacterium acnes-induced inflammation in vitro. Dermatol Ther. 2015;5:53\u201366.","journal-title":"Dermatol Ther"},{"key":"278_CR33","first-page":"135","volume":"31","author":"M Kawashima","year":"2015","unstructured":"Kawashima M, Ebihara T, Fujiwake A, Kato R. A clinical pharmacology study of ozenoxacin lotion in patients with acne vulgaris. J Clin Ther Med. 2015;31:135\u201341.","journal-title":"J Clin Ther Med"}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41429-020-0278-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41429-020-0278-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41429-020-0278-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:33:10Z","timestamp":1684618390000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41429-020-0278-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,23]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["278"],"URL":"https:\/\/doi.org\/10.1038\/s41429-020-0278-5","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,23]]},"assertion":[{"value":"25 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All the authors are employees of Maruho Co., Ltd.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}